Cell Line Development Market Size, Share & Trends Analysis Report By Offering (Cell Line Development Services, Cell Line Development Products), By Host Cell Type (CHO (CHO-K1, CHO-S, DG44 variants), HEK293 / PER.C6, NS0 / Sp2/0 (Hybridoma), Microbial (E. coli, Pichia pastoris), Insect (Sf9/Sf21), Other (Avian / Plant / Novel systems)), By Application / Molecule Type ( Monoclonal & Bispecific Antibodies, Recombinant Proteins & Enzymes Vaccines (Subunit / VLP / Recombinant), Gene & Cell Therapy Vectors (AAV / LV producer lines), Others (Hormones, Fusion Proteins, Cytokines), By Scale of Operation, By End-User Type, By Region and By Segment Forecasts, 2025-2034.
Global Cell Line Development Market Size is valued at USD 1162.61 Mn in 2024 and is predicted to reach USD 3790.05 Mn by the year 2034 at a 12.6% CAGR during the forecast period for 2025-2034. Cell line development creates highly productive, stable cell lines required for bio-therapeutic production and manufacture. These single-celled organisms create vaccines, monoclonal antibodies, and fusion proteins. Thousands of clones are screened during t...
Report ID: 2306 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
CBD API Market Size, Share & Trends Analysis Report By Source Type (Natural CBD API (Plant-Derived),Synthetic CBD API), By End Use / Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care, Research & Development / Clinical Use), By End User (Pharmaceutical & Biotech Companies, Nutraceutical / Supplement Manufacturers, Cosmetic & Personal Care Companies, Contract Manufacturing Organizations (CMOs) / CDMOs, Research Institutions & CROs), By Purity / Grade, By Form / Composition, By Region and By Segment Forecasts, 2025-2034
Global CBD API Market growth is valued at US$ 521.94 Mn in 2024 and is expected to reach US$ 2233.37 Mn by 2034, with a CAGR of 15.8% during the forecast period of 2025-2034. Key Industry Insights & Findings from the report: CBD has been recommended for a range of health conditions, it is considered the best treatment while considering the worst childhood epilepsy disorders. The increasing demand for health and wellne...
Report ID: 1478 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
RNA-based Therapeutics Market Size, Share & Trends Analysis Report By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, RNA Aptamer, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Oncology, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Others), By Delivery Mechanism (Lipid Nanoparticles (LNPs), Polymer-Based Nanoparticles, Viral Vectors, Naked RNA), By End User, By Region and By Segment Forecasts, 2025-2034
Global RNA-based Therapeutics Market is valued at USD 12.4 Bn in 2024 and is predicted to reach USD 22.6 Bn by the year 2034 at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The growing biopharmaceutical sector, characterized by increased investment and interest in innovative therapies, is propelling the RNA-based therapeutics market. The entry of new biotech startups focused on R...
Report ID: 1151 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 185
Immuno-Oncology Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (CAR-T Cells, NK & NKT Cells, TAA/TSA targeted T Cell, TCR T Cell, and Other Cell Therapies), By Cell Source, By Indication Type, By Region, And Segment Forecasts, 2025-2034
Global Immuno-Oncology Cell Therapy Market Size is valued at USD 11.9 Billion in 2024 and is predicted to reach USD 95.3 Billion by the year 2034 at a 23.2% CAGR during the forecast period for 2025-2034. Immuno-oncology cell therapies are a remarkably promising treatment for a different types of cancer patients. The approval of CAR-T cell therapy products represents one of the most significant breakthroughs in cancer since the introduction of ...
Report ID: 1083 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
GLP-1 Agonists Market Size, Share & Trends Analysis Report By Product (Branded GLP-1 Agonists, Dual / Triple, Biosimilars & Generic GLP-1 Agonists Agonists), By Indication (Type 2 Diabetes Mellitus, Obesity / Overweight Management, Cardiovascular & Metabolic Related Indications, Other Emerging Indications (e.g., NASH, Alzheimer’s-related)), By Route of Administration, By Distribution Channel, By Region and By Segments Forecasts, 2025-2034
GLP-1 Agonists Market Size is valued at USD 43.1 Bn in 2024 and is predicted to reach USD 260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034. GLP-1 agonists, known to be beneficial in treating type 2 diabetes, are glucagon-like peptide-1 receptor agonists. The action of GLP-1 RAs is to enhance insulin synthesis and inhibit glucagon secretion by activating GLP-1 receptors. While all GLP-1 RAs have the ...
Report ID: 2289 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Regenerative Aesthetics Exosome Products Market Size, Share & Trends Analysis Distribution by Application (Skin Rejuvenation, Hair Restoration, Scar Reduction and Wound Healing, Anti-Inflammatory Treatments, Others), By Biological Source, By Product Format, End User (Aesthetic Clinics, Home Use, Dermatology Clinics), and Segment Forecasts, 2025-2034
Global Regenerative Aesthetics Exosome Products Market Size is valued at USD 81.1 Million in 2024 and is predicted to reach USD 1689.7 Million by the year 2034 at a 35.9% CAGR during the forecast period for 2025-2034. Regenerative aesthetics exosome products represent a cutting-edge advancement in skin rejuvenation and hair restoration, offering a minimally invasive approach. These nano-sized extracellular vesicles derived from stem cells cont...
Report ID: 2555 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 177
Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Therapy / Modality Type (mRNA-based Therapeutics, DNA / Plasmid DNA Therapeutics, siRNA (Small Interfering RNA), Antisense Oligonucleotides (ASOs), Gene Therapy Products, Others), By Service Type (Process Development & Optimization, Drug Product (Formulation, Fill & Finish), Analytical & Quality Control (QC) Services, Regulatory Support & Technology Transfer, Packaging & Fill–Finish Services), By Workflow Stage (Preclinical Development, Clinical Manufacturing (Phase I–III), Commercial-Scale Production), By End User, By Therapeutic Area, By Region and By Segments Forecasts, 2025-2034
Global Nucleic Acid Therapeutics CDMO Market Size is valued at USD 2,540.9 Million in 2024 and is predicted to reach USD 8,688.2 Million by the year 2034 at an 13.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: A robust pipeline of nucleic acid-based drugs and high levels of investment from pharmaceutical companies and venture capitalists are boosting the market. The development of nove...
Report ID: 1348 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 185
GMP Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Product (Viral Vectors, Plasmid DNA, Non-viral, Lipid/polymer, Electroporation, Nanoparticles, Others), By Type, By Manufacturing Type, By Therapeutic Area, By Application, By Region, And By Segment Forecasts, 2025-2034
Global GMP Plasmid DNA Manufacturing Market Size is valued at USD 212.1 Million in 2024 and is predicted to reach USD 512.1 Million by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Modern medicine heavily relies on plasmid DNA (PDNA). Plasmid DNA can be utilized either explicitly for a variety of therapeutic purposes, including gene therapy and the production of vaccine antigens, or indirectly for a broad range of rese...
Report ID: 1437 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Mitochondrial-Based Therapeutics Market Size, Share and Trends Report 2026 to 2035
Global Mitochondrial-Based Therapeutics Market Size is valued at USD 388.2 Mn in 2023 and is predicted to reach USD 682.7 Mn by the year 2031 at a 7.5% CAGR during the forecast period for 2024 to 2031. Mitochondrial-Based Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Indication, By Route of Administration, By Distribution Channel...
Report ID: 2884 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 172
Preclinical Oncology Models Market Size, Share & Trends Analysis Report By Product (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Skin Cancer, Others), By Application, By Model Host Species, By Region, And Segment Forecasts, 2025-2034
Global Preclinical Oncology Models Market is valued at USD 1335.7 Million in 2024 and is predicted to reach USD 3733.0 Million by 2034, at a 10.9% CAGR during the forecast period 2025-2034. The rise of immuno-oncology therapy such as T cell therapy, bispecific antibodies, immune checkpoint modulators, and personalized cancer vaccines compels the need for unique preclinical and translational service solution. Recently advances in Immuno-oncolog...
Report ID: 1093 |
Delivery: Immediate |
Published: November 2025 |
No. of Pages: 180
Pharmaceuticals